Zdrowie i gospodarka · 15/12/2010
FDA Releases Draft Guidance on Codevelopment of Unmarketed Investigational Drugs for Combination Therapy
The FDA has made available a draft guidance to help industry sponsors develop novel, unmarketed investigational drugs in combination to treat diseases, addressing scientific and regulatory issues that arise during this process